91制片厂

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it鈥檚 official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you鈥檙e on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1961 1
1962 1
1963 4
1964 2
1965 3
1966 1
1967 1
1968 2
1970 2
1971 2
1972 1
1973 2
1974 5
1975 2
1976 6
1977 4
1978 3
1979 6
1980 9
1981 10
1982 6
1983 9
1984 12
1985 12
1986 14
1987 19
1988 14
1989 14
1990 23
1991 21
1992 37
1993 30
1994 22
1995 41
1996 27
1997 57
1998 44
1999 46
2000 41
2001 55
2002 52
2003 61
2004 62
2005 74
2006 81
2007 84
2008 83
2009 83
2010 126
2011 147
2012 124
2013 134
2014 143
2015 166
2016 170
2017 197
2018 200
2019 210
2020 229
2021 311
2022 419
2023 328
2024 229

Text availability

Article attribute

Article type

Publication date

Search Results

3,978 results

Results by year

Filters applied: . Clear all
Page 1
Vaccination and Antibody Testing in Cats.
Egberink H, Frymus T, Hartmann K, M枚stl K, Addie DD, Bel谩k S, Boucraut-Baralon C, Hofmann-Lehmann R, Lloret A, Marsilio F, Pennisi MG, Tasker S, Thiry E, Truyen U, Hosie MJ. Egberink H, et al. Viruses. 2022 Jul 22;14(8):1602. doi: 10.3390/v14081602. Viruses. 2022. PMID: 35893667 Free PMC article. Review.
Antibody testing has also been proposed to support decisions on optimal vaccination schedules for the individual kitten. However, such testing is still expensive and it is considered impractical to monitor the decline of maternally derived antibodies....
Antibody testing has also been proposed to support decisions on optimal vaccination schedules for the individual kitten. Howev 鈥�
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.
Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, Lui LMW, Cao B, Mansur RB, Ho RC, Burke MJ, Rhee TG, Rosenblat JD, McIntyre RS. Ceban F, et al. Brain Behav Immun. 2023 Jul;111:211-229. doi: 10.1016/j.bbi.2023.03.022. Epub 2023 Mar 27. Brain Behav Immun. 2023. PMID: 36990297 Free PMC article. Review.
The evidence herein supports SARS-CoV-2 vaccination for the prevention of long COVID, and recommends long COVID patients adhere to standard SARS-CoV-2 vaccination schedules....
The evidence herein supports SARS-CoV-2 vaccination for the prevention of long COVID, and recommends long COVID patients adhere to standard 鈥�
Vaccine co-administration in adults: An effective way to improve vaccination coverage.
Bonanni P, Steffen R, Schelling J, Balaisyte-Jazone L, Posiuniene I, Zato艅ski M, Van Damme P. Bonanni P, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2195786. doi: 10.1080/21645515.2023.2195786. Epub 2023 Apr 11. Hum Vaccin Immunother. 2023. PMID: 37039318 Free PMC article. Review.
Recommending bodies may consider revising vaccination schedules to reduce the number of visits....
Recommending bodies may consider revising vaccination schedules to reduce the number of visits....
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).
Lupinacci R, Rupp R, Wittawatmongkol O, Jones J, Quinones J, Ulukol B, Dagan R, Richmond P, Stek JE, Romero L, Koseoglu S, Tamms G, McFetridge R, Li J, Cheon K, Musey L, Banniettis N, Bickham K; V114-029 PNEU-PED study group. Lupinacci R, et al. Vaccine. 2023 Jan 27;41(5):1142-1152. doi: 10.1016/j.vaccine.2022.12.054. Epub 2023 Jan 6. Vaccine. 2023. PMID: 36621410 Free article. Clinical Trial.
These results support use of V114 for prevention of PD as part of routine infant vaccination schedules. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03893448; EudraCT: 2018-004109-21....
These results support use of V114 for prevention of PD as part of routine infant vaccination schedules. TRIAL REGISTRATION: Cl 鈥�
Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.
Mitkus RJ, King DB, Hess MA, Forshee RA, Walderhaug MO. Mitkus RJ, et al. Vaccine. 2011 Nov 28;29(51):9538-43. doi: 10.1016/j.vaccine.2011.09.124. Epub 2011 Oct 11. Vaccine. 2011. PMID: 22001122
We updated the analysis of Keith et al. [1] with a current pediatric vaccination schedule [2]; baseline aluminum levels at birth; an aluminum retention function that reflects changing glomerular filtration rates in infants; an adjustment for the kinetics of aluminum 鈥�
We updated the analysis of Keith et al. [1] with a current pediatric vaccination schedule [2]; baseline aluminum levels at bir 鈥�
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Watson-Jones D, Changalucha J, Whitworth H, Pinto L, Mutani P, Indangasi J, Kemp T, Hashim R, Kamala B, Wiggins R, Songoro T, Connor N, Mbwanji G, Pavon MA, Lowe B, Mmbando D, Kapiga S, Mayaud P, de SanJos茅 S, Dillner J, Hayes RJ, Lacey CJ, Baisley K. Watson-Jones D, et al. Lancet Glob Health. 2022 Oct;10(10):e1473-e1484. doi: 10.1016/S2214-109X(22)00309-6. Lancet Glob Health. 2022. PMID: 36113531 Free PMC article. Clinical Trial.
BACKGROUND: An estimated 15% of girls aged 9-14 years worldwide have been vaccinated against human papillomavirus (HPV) with the recommended two-dose or three-dose schedules. A one-dose HPV vaccine schedule would be simpler and cheaper to deliver. We report immunoge 鈥�
BACKGROUND: An estimated 15% of girls aged 9-14 years worldwide have been vaccinated against human papillomavirus (HPV) with the recommended 鈥�
Vaccines and Senior Travellers.
Ecarnot F, Maggi S, Michel JP, Veronese N, Rossanese A. Ecarnot F, et al. Front Aging. 2021 Jul 9;2:677907. doi: 10.3389/fragi.2021.677907. eCollection 2021. Front Aging. 2021. PMID: 35822022 Free PMC article. Review.
Older individuals should be advised about the vaccines that are recommended for their age group in the framework of the national vaccination schedule. Travel-specific vaccines must be discussed in detail on a case-by-case basis, and the risk associated with the vacc 鈥�
Older individuals should be advised about the vaccines that are recommended for their age group in the framework of the national vaccinat 鈥�
Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review.
Feemster K, Weaver J, Buchwald U, Banniettis N, Cox KS, McIntosh ED, Spoulou V. Feemster K, et al. Vaccines (Basel). 2023 Nov 24;11(12):1750. doi: 10.3390/vaccines11121750. Vaccines (Basel). 2023. PMID: 38140155 Free PMC article. Review.
This targeted literature review aims to discuss aspects of vaccine breakthrough and failure in infants and children, including disease epidemiology, clinical presentation, risk factors, vaccination schedules, vaccine serotypes, correlates of protection, comorbiditie 鈥�
This targeted literature review aims to discuss aspects of vaccine breakthrough and failure in infants and children, including disease epide 鈥�
Vaccination in children with immune-mediated disorders.
Marinho AKBB. Marinho AKBB. J Pediatr (Rio J). 2023 Mar-Apr;99 Suppl 1(Suppl 1):S62-S69. doi: 10.1016/j.jped.2022.11.008. Epub 2022 Dec 21. J Pediatr (Rio J). 2023. PMID: 36566017 Free PMC article. Review.
The patients should be informed about the possibility that the immunization may fail during treatment with immunosuppressants. Specific vaccination schedules should be considered to ensure better protection. CONCLUSIONS: Recent studies have allowed updating the reco 鈥�
The patients should be informed about the possibility that the immunization may fail during treatment with immunosuppressants. Specific v 鈥�
Immune Dysfunction in Aged Horses.
McFarlane D. McFarlane D. Vet Clin North Am Equine Pract. 2016 Aug;32(2):333-41. doi: 10.1016/j.cveq.2016.04.009. Epub 2016 Jun 18. Vet Clin North Am Equine Pract. 2016. PMID: 27329495 Review.
Specific recommendations for immune modification of older horses, including an age-appropriate vaccination schedule, are not currently available. In addition, the effect of old age on risk of infectious disease is poorly documented. ...
Specific recommendations for immune modification of older horses, including an age-appropriate vaccination schedule, are not c 鈥�
3,978 results